Latest Breaking News On - Equine pain away - Page 1 : vimarsana.com

Head-To-Head Survey: Nutra Pharma (OTCMKTS:NPHC) versus FitLife Brands (NASDAQ:FTLF)

Financial Survey: FitLife Brands (NASDAQ:FTLF) vs. Nutra Pharma (OTCMKTS:NPHC)

Head to Head Review: Ayr Wellness (OTCMKTS:AYRWF) versus Nutra Pharma (OTCMKTS:NPHC)

Nutra Pharma (OTCMKTS:NPHC – Get Rating) and Ayr Wellness (OTCMKTS:AYRWF – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, institutional ownership, earnings and risk. Profitability This table compares Nutra Pharma and Ayr Wellness’ […]

Nutra Pharma Announces First Manufacturing Agreement

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Nutra Pharma Expands Manufacturing Capabilities

Nutra Pharma is providing updates on their work in improving manufacturing scale and capabilities for new product launches for their OTC drugs and.

Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures

Nutra Pharma Corporation: Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and anti-inflammatory drugs Plantation, Florida (Newsfile Corp. - June 4, 2021)

Nutra Pharma Announces Influencer and Social Media Campaign for | The Kingston Whig Standard

Article content Plantation, Florida–(Newsfile Corp. – May 24, 2021) – Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today their plans for expanding the marketing of their over-the-counter pain relievers and anti-inflammatory products by working with influencers on several social media platforms. These will include celebrities as well as professional and Olympic athletes that have benefitted from Nutra Pharma’s products. We apologize, but this video has failed to load. Try refreshing your browser.

Nutra Pharma Corporation: Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon

Nutra Pharma Corporation: Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials

Nutra Pharma Corporation: Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation in preparation of expanded OTC sales and clinical trials Plantation, Florida (Newsfile Corp. - March 11, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, is providing updates today on their work in improving their existing facilities for manufacturing and validation of their drug products; including their technologies for the treatment of Multiple Sclerosis (MS) and potential countermeasures against nerve agents like sarin gas and VX. As part of this process, Nutra Pharma today announ